{"id":301012,"date":"2019-11-01T23:30:40","date_gmt":"2019-11-02T06:30:40","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/11\/seneca-biopharma-and-jiangsu-qyuns-therapeutics-announce-development-plan-for-potential-joint-pipeline-at-7th-china-renaissance-healthcare-and-life-science-leadership-summit\/"},"modified":"2019-11-02T00:01:52","modified_gmt":"2019-11-02T07:01:52","slug":"seneca-biopharma%e8%81%af%e5%90%88%e4%b8%ad%e5%9c%8b%e4%bc%81%e6%a5%ad%e6%b7%b1%e8%80%95%e4%b8%ad%e5%9c%8b%e5%b8%82%e5%a0%b4","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/11\/seneca-biopharma%e8%81%af%e5%90%88%e4%b8%ad%e5%9c%8b%e4%bc%81%e6%a5%ad%e6%b7%b1%e8%80%95%e4%b8%ad%e5%9c%8b%e5%b8%82%e5%a0%b4\/","title":{"rendered":"\u53c8\u4e00\u5bb6\u516c\u53f8\u7784\u5411\u4e2d\u570b\u5e02\u5834\uff0cSeneca Biopharma\u806f\u5408\u4e2d\u570b\u4f01\u696d\u6df1\u8015\u4e2d\u570b\u5e02\u5834"},"content":{"rendered":"<p>Seneca Biopharma, Inc.\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aSCNA\uff09\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u91dd\u5c0d\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u75be\u75c5\u7684\u65b0\u7642\u6cd5\uff0c\u800c\u6c5f\u8607\u8343\u4fe1\u751f\u7269\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u201c\u8343\u4fe1\u201d\uff09\u5247\u662f\u4e00\u5bb6\u5c08\u6ce8\u4e8e\u55ae\u514b\u9686\u6297\u9ad4\u7642\u6cd5\u7684\u4e2d\u570b\u516c\u53f8\u3002\u96d9\u65b9\u5728\u4e00\u5834\u5cf0\u6703\u4e0a\u5ba3\u4f48\u4e86\u7528\u65bc\u6cbb\u7642\u514d\u75ab\u6027\u75be\u75c5\u7684\u7522\u54c1\u806f\u5408\u7522\u54c1\u958b\u767c\u8a08\u5283\u3002<\/p>\n<p>Seneca Biopharma, Inc.\u9996\u5e2d\u91ab\u5b78\u5b98\u3001\u91ab\u5b78\u535a\u58ebDavid Recker\u8868\u793a\uff1a\u201c\u9019\u7a2e\u5019\u9078\u7522\u54c1\u6709\u53ef\u80fd\u5c0d\u591a\u7a2e\u514d\u75ab\u548c\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u7684\u60a3\u8005\u7d50\u679c\u7522\u751f\u7a4d\u6975\u800c\u6301\u4e45\u7684\u5f71\u97ff\u3002SCA005 \/ QX005N\u5177\u6709\u6cbb\u7642\u54ee\u5598\u548c\u7279\u61c9\u6027\u76ae\u708e\u7684\u7279\u6b8a\u524d\u666f\u3002\u201d<\/p>\n<p>\u8343\u4fe1\u7684\u8cc7\u7522\u5305\u62ec\u91dd\u5c0dIL-4R\u03b1\u7684QX005N\u3001\u91dd\u5c0dIL-17A\u7684QX002N\u3001\u91dd\u5c0dIL-23A\u7684QX004N\u548c\u91dd\u5c0dIFNR\u03b1\u7684QX006N\u3002\u5169\u5bb6\u516c\u53f8\u671f\u671b\u5728\u5168\u7403\u7bc4\u570d\u5167\u5171\u540c\u958b\u767c\u9019\u4e9b\u8cc7\u7522\uff0c\u4e26\u5728\u672a\u4f86\u7684\u7522\u54c1\u64f4\u5c55\u65b9\u9762\u9032\u884c\u5408\u4f5c\u3002\u7c3d\u7f72\u8a31\u53ef\u5354\u8b70\u5f8c\uff0cSeneca\u7684\u4e3b\u8981\u8cc7\u7522\u5c07\u70baSNC005\uff08QX005N\uff09\uff0c\u5176\u91dd\u5c0dIL-4R\u03b1\u7684\u76ee\u6a19\u662f\u6cbb\u7642\u54ee\u5598\u548c\u7279\u61c9\u6027\u76ae\u708e\u3002<\/p>\n<p>\u8343\u4fe1\u9996\u5e2d\u904b\u71df\u5b98Yiliang Wu\u6307\u51fa\uff1a\u201c\u6211\u5011\u7684\u5e73\u81fa\u5df2\u7d93\u751f\u7522\u51fa\u516d\u7a2e\u65b0\u7a4e\u7684\u5019\u9078\u85e5\u7269\uff0c\u5b83\u5011\u8655\u65bc\u81e8\u5e8a\u524d\u548c\u81e8\u5e8a\u7814\u7a76\u7684\u4e0d\u540c\u968e\u6bb5\u3002\u9019\u7a2e\u5408\u4f5c\u95dc\u4fc2\u5c07\u4f7f\u6211\u5011\u80fd\u5920\u5229\u7528Seneca\u4e16\u754c\u4e00\u6d41\u7ba1\u7406\u5718\u968a\u7684\u7d93\u9a57\u4f86\u52a0\u901f\u9019\u4e9b\u6709\u524d\u9014\u7684\u7642\u6cd5\u7684\u5168\u7403\u5546\u696d\u5316\u3002\u201d<\/p>\n<p>Seneca Biopharma, Inc.\uff08NASDAQ\uff1aSCNA\uff09\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u91dd\u5c0d\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u75be\u75c5\u7684\u65b0\u578b\u7642\u6cd5\u3002Seneca\u6b63\u5728\u5c0b\u627e\u548c\u6536\u8cfc\u65b0\u8cc7\u7522\u3001\u6709\u524d\u9014\u7684\u79d1\u5b78\u548c\u6280\u8853\uff0c\u9019\u4e9b\u65b0\u6280\u8853\u5c07\u70ba\u60a3\u8005\u5e36\u4f86\u6709\u610f\u7fa9\u7684\u7642\u6cd5\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seneca Biopharma, Inc., (NASDAQ: SCNA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, and Jiangsu QYuns Therapeutics Co., Ltd., a China-based company focused on monoclonal antibody therapeutics, jointly announce development plans for a joint pipeline of products for the treatment of immunological diseases<\/p>\n","protected":false},"author":9,"featured_media":301000,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,564],"class_list":["post-301012","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/301012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=301012"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/301012\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/301000"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=301012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=301012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=301012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}